March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Learn what vitamins and minerals are, and get some suggestions about what supplements HIV+ women may want to take and which ones to avoid.
Get basic information about how the immune system works, its key parts, and how HIV damages it.
Learn what hyperlipidemia is, how to know if you have it, and options for lowering your lipid levels, including important tips on dietary fats.